Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.15% | -7.88% | -210.29% | -3.02% | -24.84% |
| Total Depreciation and Amortization | -- | -- | -100.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -- |
| Total Other Non-Cash Items | 10.95% | 18.09% | 851.17% | 316.30% | -7.07% |
| Change in Net Operating Assets | -227.98% | -33.33% | 297.57% | -233.79% | 493.60% |
| Cash from Operations | -95.45% | -23.73% | 11.51% | -95.54% | 22.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 49.29% | -40.00% | -- | 100.00% |
| Issuance of Common Stock | -94.62% | -97.54% | 3,276.69% | 97,600.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 39.13% | 90.61% | -10.11% | -- | 100.00% |
| Cash from Financing | -95.31% | -97.61% | 3,805.17% | 83,975.00% | 101.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -884.94% | -100.59% | 67,566.84% | 89.52% | 30.03% |